FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/11/097360 [Registered on: 13/11/2025] Trial Registered Prospectively
Last Modified On: 11/11/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Evaluation of hyperbaric ropivacaine drug effect when given in single shot spinal anesthesia versus low dose combined spinal epidural anaesthesia in patient groups having cardiac disease and undergoing hip fracture surgery. 
Scientific Title of Study   Evaluation of efficacy and safety of hyperbaric ropivacaine in single dose spinal versus low dose combined spinal epidural anaesthesia among cardiac patients undergoing hip fracture surgery: A randomized comparative study 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Udita Naithani  
Designation  Professor 
Affiliation  R.N.T medical college  
Address  Department of Anaesthesia, R.N.T Medical college, Udaipur, Rajasthan

Udaipur
RAJASTHAN
313001
India 
Phone  9829414752  
Fax    
Email  Uditanaithani@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Udita Naithani  
Designation  Professor 
Affiliation  R.N.T medical college  
Address  Department of Anaesthesia, R.N.T Medical college, Udaipur, Rajasthan

Udaipur
RAJASTHAN
313001
India 
Phone  9829414752  
Fax    
Email  Uditanaithani@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Deeksha Chandra  
Designation  Pg Resident 
Affiliation  R.N.T Medical college  
Address  Department of Anaesthesia, R.N.T Medical college, Udaipur, Rajasthan

Udaipur
RAJASTHAN
313001
India 
Phone  7895147150  
Fax    
Email  deekshachandra96@gmail.com  
 
Source of Monetary or Material Support  
Department of Anaesthesia, RNT Medical College, Udaipur, Rajasthan, 313001 
 
Primary Sponsor  
Name  Maharana Bhupal Government Hospital  
Address  Department of Anaesthesia, R.N.T Medical college, Udaipur, Rajasthan 313001 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Udita Naithani   Maharana Bhupal Hospital   Department of Orthopedics, Orthopedics operation theatre,Operating Room 1 and 2. 2nd floor, polytrauma Building, Maharana Bhupal hospital, RNT Medical College, Udaipur, Rajasthan 313001
Udaipur
RAJASTHAN 
9829414752

Uditanaithani@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
RNT MEDICAL COLLEGE AND CONTROLLER AND ATTACHED HOSPITALS, UDAIPUR  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M899||Disorder of bone, unspecified, (2) ICD-10 Condition: W108||Fall (on) (from) other stairs andsteps, (3) ICD-10 Condition: W06||Fall from bed, (4) ICD-10 Condition: W07||Fall from chair, (5) ICD-10 Condition: W15||Fall from cliff, (6) ICD-10 Condition: S720||Fracture of head and neck of femur, (7) ICD-10 Condition: S720||Fracture of head and neck of femur, (8) ICD-10 Condition: S720||Fracture of head and neck of femur, (9) ICD-10 Condition: O||Medical and Surgical, (10) ICD-10 Condition: O||Medical and Surgical, (11) ICD-10 Condition: O||Medical and Surgical, (12) ICD-10 Condition: V235||Motorcycle passenger injured in collision with car, pick-up truck or van in traffic accident, (13) ICD-10 Condition: S710||Open wound of hip, (14) ICD-10 Condition: V011||Pedestrian injured in collision with pedal cycle in traffic accident, (15) ICD-10 Condition: M161||Unilateral primary osteoarthritisof hip,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  0.75% hyperbaric ropivacaine in combined spinal epidural anaesthesia   Patients will receive intrathecal injection of 1.75 ml 0.75% hyperbaric ropivacaine and 0.25 ml fentanyl (total 2ml)in L4-L5 space followed by injection of 6 ml 0.5% isobaric ropivacaine via epidural catheter after 5 minutes of intrathecal injection  
Comparator Agent  0.75% hyperbaric ropivacaine in single shot spinal anaesthesia   Patients will receive subarachnoid block using intrathecal injection of 2.25 ml 0.75% hyperbaric ropivacaine and 0.25 ml fentanyl. 
Intervention  To compare the incidence of hypotension   To determine the incidence of intraoperative hypotension for 150 minutes in patients receiving 0.75% hyperbaric ropivacaine in single shot spinal anesthesia compared with combined spinal epidural anaesthesia  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  Patients of 18 years or above, of both sex, ASA grade 2 to 4, having preexisting cardiac disease and undergoing elective hip fracture surgery of expected duration of 2 hours 
 
ExclusionCriteria 
Details  Any contraindications to spinal anesthesia, allergic to local anesthetics, patient refusal, if patient is converted to GA and pregnancy 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To compare incidence of intraoperative hypotension   To compare incidence of intraoperative hypotension at baseline, time of induction, at 3, 6,9 12, 15 , 20, 25, 30,35,40,45,50,55,60,75,90,105,120,135 and 150 minutes after induction.  
 
Secondary Outcome  
Outcome  TimePoints 
To compare sensory & motor block characteristics  Sensory & motor block characteristics were noted at 3, 6, 9, 12, 15 & 20 minutes after induction 
Hemodynamic profile including systolic BP,diastolic BP,Mean Arterial pressure, Heart Rate & oxygen saturation   Hemodynamic vitals noted at baseline, time of induction, 3,6,9,12,15,20,25,30,35,40,45,50,55,60,75,90,105,120,135 & 150 minutes post induction 
Adverse cardiac events occurring intraoperatively & postoperatively  Adverse cardiac effects noted for 48 hours postoperatively 
 
Target Sample Size   Total Sample Size="140"
Sample Size from India="140" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   25/11/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="8"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Hip fractures in elderly population are associated high mortality. Postoperative cardioevents are frequent accounting for around 40% of all reported complications among patients receiving hip fracture surgery. Most patients with hip fractures are fragile and preexisting CVD combined with acute trauma as well as surgical stress could potentially increase the risk of post operative cardiovascular events. Not many comparative studies of CSE versus single dose spinal anaesthesia using hyperbaric ropivacaine in cardiac patients undergoing hip fracture surgery to assess the effect on perioperative hypotension and adverse cardiac effects have been done.We are therefore planning to compare clinical efficacy and safety profile of 0.75% hyperbaric ropivacaine when administered in single dose spinal anesthesia versus low dose combined spinal epidural anesthesia in cardiac patients undergoing hip fracture surgeries. Primary outcome measuredwill be incidence of hypotension and secondary outcomes measured will be sensory-motor block characteristics , quality of anaesthesia, hemodynamic profile, adverse effects and adverse cardiac events occurring during first 48 hours.  
Close